3-AMINO-2-(4-CHLOROPHENYL)-NITROPROPANE IS A NEW GABA(B) RECEPTOR AGONIST, MORE ACTIVE PERIPHERALLY

The activity of the nitropropane analog of baclofen, 3-amino-2-(4-chlo rophenyl)-nitropropane (N-BAC), has been examined at central and perip heral GABA(B) receptors. N-BAC was less potent than baclofen as a GABA (B) receptor agonist in depressing repetitive twitch contractions in t he guinea-pig isolated ileum (IC50s for baclofen = 4.1 +/- 1.3 muM; N- BAC = 9.2 +/- 0.3 muM) and vas deferens (IC50s for baclofen = 30 muM; N-BAC = 100 muM), competitively antagonised by phaclofen, 2-hydroxysac lofen and CGP 35348 (3-aminopropyl-P-di-ethoxymethylphosphinic acid). In the ileum, the pA2 values for CGP 35348 with baclofen (4.7 +/- 0.2) and N-BAC (4.6 +/- 0.3) were not significantly different (P > 0.05), indicating that both agonists activate the same receptor type. By cont rast, in rat neocortical slices, N-BAC was 20 times weaker than baclof en in attenuating spontaneous discharges, sensitive to CGP 35348, whil st it was 100 times less potent than baclofen in depressing evoked CA1 population spikes in the hippocampus. This new GABA(B) receptor agoni st, N-BAC, is thus more active at peripheral than central GABA(B) rece ptors.